Year |
Citation |
Score |
2022 |
Skelton PD, Tokars V, Parisiadou L. LRRK2 at Striatal Synapses: Cell-Type Specificity and Mechanistic Insights. Cells. 11. PMID 35011731 DOI: 10.3390/cells11010169 |
0.338 |
|
2017 |
Tayebi N, Parisiadou L, Berhe B, Gonzalez AN, Serra-Vinardell J, Tamargo RJ, Maniwang E, Sorrentino Z, Fujiwara H, Grey RJ, Hassan S, Blech-Hermoni YN, Chen C, McGlinchey R, Makariou-Pikis C, et al. Glucocerebrosidase haploinsufficiency in A53T α-synuclein mice impacts disease onset and course. Molecular Genetics and Metabolism. 122: 198-208. PMID 29173981 DOI: 10.1016/J.Ymgme.2017.11.001 |
0.349 |
|
2015 |
Liu G, Sgobio C, Gu X, Sun L, Lin X, Yu J, Parisiadou L, Xie C, Sastry N, Ding J, Lohr KM, Miller GW, Mateo Y, Lovinger DM, Cai H. Selective Expression of Parkinson's disease-related Leucine-rich Repeat Kinase 2 G2019S Missense Mutation in Midbrain Dopaminergic Neurons Impairs Dopamine Release and Dopaminergic Gene Expression. Human Molecular Genetics. PMID 26123485 DOI: 10.1093/Hmg/Ddv249 |
0.564 |
|
2014 |
Cho HJ, Yu J, Xie C, Rudrabhatla P, Chen X, Wu J, Parisiadou L, Liu G, Sun L, Ma B, Ding J, Liu Z, Cai H. Leucine-rich repeat kinase 2 regulates Sec16A at ER exit sites to allow ER-Golgi export. The Embo Journal. 33: 2314-31. PMID 25201882 DOI: 10.15252/Embj.201487807 |
0.578 |
|
2014 |
Luo J, Sun L, Lin X, Liu G, Yu J, Parisiadou L, Xie C, Ding J, Cai H. A calcineurin- and NFAT-dependent pathway is involved in α-synuclein-induced degeneration of midbrain dopaminergic neurons. Human Molecular Genetics. 23: 6567-74. PMID 25051958 DOI: 10.1093/Hmg/Ddu377 |
0.569 |
|
2014 |
Parisiadou L, Yu J, Sgobio C, Xie C, Liu G, Sun L, Gu XL, Lin X, Crowley NA, Lovinger DM, Cai H. LRRK2 regulates synaptogenesis and dopamine receptor activation through modulation of PKA activity. Nature Neuroscience. 17: 367-76. PMID 24464040 DOI: 10.1038/Nn.3636 |
0.57 |
|
2014 |
Tao R, Vassilopoulos A, Parisiadou L, Yan Y, Gius D. Regulation of MnSOD enzymatic activity by Sirt3 connects the mitochondrial acetylome signaling networks to aging and carcinogenesis. Antioxidants & Redox Signaling. 20: 1646-54. PMID 23886445 DOI: 10.1089/Ars.2013.5482 |
0.333 |
|
2014 |
Parisiadou L, Yu J, Sgobio C, Xie C, Liu G, Sun L, Gu X, Lin X, Crowley NA, Lovinger DM, Cai H. Erratum: Corrigendum: LRRK2 regulates synaptogenesis and dopamine receptor activation through modulation of PKA activity Nature Neuroscience. 17: 1287-1287. DOI: 10.1038/Nn0914-1287B |
0.493 |
|
2013 |
Cho HJ, Liu G, Jin SM, Parisiadou L, Xie C, Yu J, Sun L, Ma B, Ding J, Vancraenenbroeck R, Lobbestael E, Baekelandt V, Taymans JM, He P, Troncoso JC, et al. MicroRNA-205 regulates the expression of Parkinson's disease-related leucine-rich repeat kinase 2 protein. Human Molecular Genetics. 22: 608-20. PMID 23125283 DOI: 10.1093/Hmg/Dds470 |
0.564 |
|
2012 |
Lin X, Parisiadou L, Sgobio C, Liu G, Yu J, Sun L, Shim H, Gu XL, Luo J, Long CX, Ding J, Mateo Y, Sullivan PH, Wu LG, Goldstein DS, et al. Conditional expression of Parkinson's disease-related mutant α-synuclein in the midbrain dopaminergic neurons causes progressive neurodegeneration and degradation of transcription factor nuclear receptor related 1. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 32: 9248-64. PMID 22764233 DOI: 10.1523/Jneurosci.1731-12.2012 |
0.584 |
|
2010 |
Parisiadou L, Cai H. LRRK2 function on actin and microtubule dynamics in Parkinson disease. Communicative & Integrative Biology. 3: 396-400. PMID 21057624 DOI: 10.4161/Cib.3.5.12286 |
0.547 |
|
2009 |
Lin X, Parisiadou L, Gu XL, Wang L, Shim H, Sun L, Xie C, Long CX, Yang WJ, Ding J, Chen ZZ, Gallant PE, Tao-Cheng JH, Rudow G, Troncoso JC, et al. Leucine-rich repeat kinase 2 regulates the progression of neuropathology induced by Parkinson's-disease-related mutant alpha-synuclein. Neuron. 64: 807-27. PMID 20064389 DOI: 10.1016/J.Neuron.2009.11.006 |
0.553 |
|
2009 |
Parisiadou L, Xie C, Cho HJ, Lin X, Gu XL, Long CX, Lobbestael E, Baekelandt V, Taymans JM, Sun L, Cai H. Phosphorylation of ezrin/radixin/moesin proteins by LRRK2 promotes the rearrangement of actin cytoskeleton in neuronal morphogenesis. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 29: 13971-80. PMID 19890007 DOI: 10.1523/Jneurosci.3799-09.2009 |
0.557 |
|
2008 |
Parisiadou L, Bethani I, Michaki V, Krousti K, Rapti G, Efthimiopoulos S. Homer2 and Homer3 interact with amyloid precursor protein and inhibit Abeta production. Neurobiology of Disease. 30: 353-64. PMID 18387811 DOI: 10.1016/J.Nbd.2008.02.004 |
0.622 |
|
2008 |
Wang L, Xie C, Greggio E, Parisiadou L, Shim H, Sun L, Chandran J, Lin X, Lai C, Yang WJ, Moore DJ, Dawson TM, Dawson VL, Chiosis G, Cookson MR, et al. The chaperone activity of heat shock protein 90 is critical for maintaining the stability of leucine-rich repeat kinase 2. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 28: 3384-91. PMID 18367605 DOI: 10.1523/Jneurosci.0185-08.2008 |
0.694 |
|
2007 |
Fassa A, Parisiadou L, Robakis NK, Efthimiopoulos S. Novel processing of Notch 1 within its intracellular domain by a cysteine protease. Neuro-Degenerative Diseases. 4: 148-55. PMID 17596709 DOI: 10.1159/000101839 |
0.652 |
|
2007 |
Parisiadou L, Efthimiopoulos S. Expression of mDab1 promotes the stability and processing of amyloid precursor protein and this effect is counteracted by X11alpha. Neurobiology of Aging. 28: 377-88. PMID 16458391 DOI: 10.1016/J.Neurobiolaging.2005.12.015 |
0.635 |
|
2004 |
Parisiadou L, Fassa A, Fotinopoulou A, Bethani I, Efthimiopoulos S. Presenilin 1 and cadherins: stabilization of cell-cell adhesion and proteolysis-dependent regulation of transcription. Neuro-Degenerative Diseases. 1: 184-91. PMID 16908988 DOI: 10.1159/000080984 |
0.639 |
|
2004 |
Braungart E, Gerlach M, Riederer P, Baumeister R, Hoener MC, Silva OABdCe, Vieira SI, Silva EFdCe, Froelich-Fabre S, Skoglund L, Ostojic J, Kilander L, Lindau M, Rebelo S, Hartmann D, ... ... Parisiadou L, et al. DIADEM / Participants Directory Neurodegenerative Diseases. 1: 243-244. DOI: 10.1159/000082213 |
0.544 |
|
Show low-probability matches. |